Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12.14 USD | +0.29% |
|
+32.26% | +412.50% |
Jul. 09 | Emergent Biosolutions, Johnson & Johnson Settle Dispute Over COVID-19 Vaccine Manufacturing | MT |
Jul. 08 | Emergent, J&J settle COVID vaccine supply deal dispute | RE |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+412.50% | 635M | |
+56.98% | 848B | |
+31.64% | 627B | |
-0.56% | 363B | |
+15.28% | 318B | |
+12.35% | 299B | |
+15.51% | 243B | |
+16.72% | 225B | |
+16.20% | 179B | |
+3.23% | 167B |
- Stock Market
- Equities
- EBS Stock
- News Emergent BioSolutions Inc.
- Transcript : Emergent BioSolutions Inc., Q2 2023 Earnings Call, Aug 08, 2023